메뉴 건너뛰기




Volumn 21, Issue 2, 2017, Pages 175-181

Pleiotropic effects of statins on acute kidney injury: involvement of Krüppel-like factor 4

Author keywords

3 Hydroxy 3 methylglutaryl coenzyme A; Cholesterol; Kr ppel like factors; Pleiotropic effect

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 6; KRUPPEL LIKE FACTOR; PROTECTIVE AGENT;

EID: 84974846105     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-016-1286-4     Document Type: Article
Times cited : (12)

References (60)
  • 1
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
    • COI: 1:CAS:528:DyaK28Xhslemsw%3D%3D, PID: 7566020
    • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301–7.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3    Isles, C.G.4    Lorimer, A.R.5    MacFarlane, P.W.6    McKillop, J.H.7    Packard, C.J.8
  • 3
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
    • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–9.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 5
    • 26844564725 scopus 로고    scopus 로고
    • The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes
    • COI: 1:CAS:528:DC%2BD2MXhtFWht7zE, PID: 16226165
    • Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005;46:1425–33.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1425-1433
    • Ray, K.K.1    Cannon, C.P.2
  • 6
    • 77951716673 scopus 로고    scopus 로고
    • Statin therapy—part I: the pleiotropic effects of statins in cardiovascular disease
    • Sadowitz B, Maier KG, Gahtan V. Statin therapy—part I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovasc Surg. 2010;44:241–51.
    • (2010) Vasc Endovasc Surg , vol.44 , pp. 241-251
    • Sadowitz, B.1    Maier, K.G.2    Gahtan, V.3
  • 7
    • 84906791819 scopus 로고    scopus 로고
    • Cardiovascular effects of statins, beyond the lipid-lowering properties
    • COI: 1:CAS:528:DC%2BC2cXkslehtbw%3D, PID: 24631782
    • Mihos CG, Pineda AM, Santana O. Cardiovascular effects of statins, beyond the lipid-lowering properties. Pharmacol Res. 2014;88:12–9.
    • (2014) Pharmacol Res , vol.88 , pp. 12-19
    • Mihos, C.G.1    Pineda, A.M.2    Santana, O.3
  • 8
    • 0035963529 scopus 로고    scopus 로고
    • Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
    • COI: 1:CAS:528:DC%2BD3MXltFersrc%3D, PID: 11430324
    • Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr, the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;344:1959–65.
    • (2001) N Engl J Med , vol.344 , pp. 1959-1965
    • Ridker, P.M.1    Rifai, N.2    Clearfield, M.3    Downs, J.R.4    Weis, S.E.5    Miles, J.S.6    Gotto, A.M.7
  • 10
    • 84937641883 scopus 로고    scopus 로고
    • Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies
    • COI: 1:CAS:528:DC%2BC2MXmsVersrw%3D, PID: 25890842
    • Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J. Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies. Cancer Treat Rev. 2015;41:554–67.
    • (2015) Cancer Treat Rev , vol.41 , pp. 554-567
    • Zhong, S.1    Zhang, X.2    Chen, L.3    Ma, T.4    Tang, J.5    Zhao, J.6
  • 11
    • 26244441019 scopus 로고    scopus 로고
    • The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
    • Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Resp Res. 2005;6:82.
    • (2005) Resp Res , vol.6 , pp. 82
    • Mortensen, E.M.1    Restrepo, M.I.2    Anzueto, A.3    Pugh, J.4
  • 12
    • 54949095097 scopus 로고    scopus 로고
    • Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients
    • PID: 18955636
    • Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med. 2008;168:2081–7.
    • (2008) Arch Intern Med , vol.168 , pp. 2081-2087
    • Thomsen, R.W.1    Riis, A.2    Kornum, J.B.3    Christensen, S.4    Johnsen, S.P.5    Sørensen, H.T.6
  • 13
    • 84906791607 scopus 로고    scopus 로고
    • Statins, bone metabolism and treatment of bone catabolic diseases
    • COI: 1:CAS:528:DC%2BC2cXhtlKhu7Y%3D, PID: 24407282
    • Zhang Y, Bradley AD, Wang D, Reinhardt RA. Statins, bone metabolism and treatment of bone catabolic diseases. Pharmacol Res. 2014;88:53–61.
    • (2014) Pharmacol Res , vol.88 , pp. 53-61
    • Zhang, Y.1    Bradley, A.D.2    Wang, D.3    Reinhardt, R.A.4
  • 17
    • 84884213500 scopus 로고    scopus 로고
    • Effect of statin use on acute kidney injury risk following coronary artery bypass grafting
    • COI: 1:CAS:528:DC%2BC3sXhs1Witg%3D%3D, PID: 23273532
    • Layton JB, Kshirsagar AV, Simpson RJ Jr, Pate V, Funk MJ, Stürmer T, Brookhart MA. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol. 2013;111:823–8.
    • (2013) Am J Cardiol , vol.111 , pp. 823-828
    • Layton, J.B.1    Kshirsagar, A.V.2    Simpson, R.J.3    Pate, V.4    Funk, M.J.5    Stürmer, T.6    Brookhart, M.A.7
  • 18
    • 84937734258 scopus 로고    scopus 로고
    • Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients
    • PID: 26081692
    • Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051–60.
    • (2015) Can J Cardiol , vol.31 , pp. 1051-1060
    • Wang, J.1    Gu, C.2    Gao, M.3    Yu, W.4    Yu, Y.5
  • 19
    • 34249685010 scopus 로고    scopus 로고
    • Mevalonate pathway: a review of clinical and therapeutical implications
    • COI: 1:CAS:528:DC%2BD2sXmtVGrs7w%3D, PID: 17467679
    • Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem. 2007;40:575–84.
    • (2007) Clin Biochem , vol.40 , pp. 575-584
    • Buhaescu, I.1    Izzedine, H.2
  • 20
    • 0027490174 scopus 로고
    • SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene
    • COI: 1:CAS:528:DyaK2cXkslajuw%3D%3D, PID: 8402897
    • Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75:187–97.
    • (1993) Cell , vol.75 , pp. 187-197
    • Yokoyama, C.1    Wang, X.2    Briggs, M.R.3    Admon, A.4    Wu, J.5    Hua, X.6    Goldstein, J.L.7    Brown, M.S.8
  • 21
    • 0028225462 scopus 로고
    • SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
    • COI: 1:CAS:528:DyaK2cXis1KmsLw%3D, PID: 8156598
    • Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 1994;77:53–62.
    • (1994) Cell , vol.77 , pp. 53-62
    • Wang, X.1    Sato, R.2    Brown, M.S.3    Hua, X.4    Goldstein, J.L.5
  • 23
    • 0032554676 scopus 로고    scopus 로고
    • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
    • West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 1998;97:1440–5.
    • (1998) Circulation , vol.97 , pp. 1440-1445
  • 24
    • 70749119012 scopus 로고    scopus 로고
    • Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure
    • COI: 1:CAS:528:DC%2BD1MXhsFagsbjF, PID: 19962481
    • Lipinski MJ, Cauthen CA, Biondi-Zoccai GG, Abbate A, Vrtovec B, Khan BV, Vetrovec GW. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure. Am J Cardiol. 2009;104:1708–16.
    • (2009) Am J Cardiol , vol.104 , pp. 1708-1716
    • Lipinski, M.J.1    Cauthen, C.A.2    Biondi-Zoccai, G.G.3    Abbate, A.4    Vrtovec, B.5    Khan, B.V.6    Vetrovec, G.W.7
  • 25
    • 1042268126 scopus 로고    scopus 로고
    • Statins induce the regression of left ventricular mass in patients with angina
    • COI: 1:CAS:528:DC%2BD2cXhsVGhsb0%3D, PID: 14745145
    • Nishikawa H, Miura S, Zhang B, Shimomura H, Arai H, Tsuchiya Y, Matsuo K, Saku K. Statins induce the regression of left ventricular mass in patients with angina. Circ J. 2004;68:121–5.
    • (2004) Circ J , vol.68 , pp. 121-125
    • Nishikawa, H.1    Miura, S.2    Zhang, B.3    Shimomura, H.4    Arai, H.5    Tsuchiya, Y.6    Matsuo, K.7    Saku, K.8
  • 26
    • 39149142513 scopus 로고    scopus 로고
    • Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials
    • COI: 1:CAS:528:DC%2BD1cXitlequ7k%3D, PID: 18294568
    • Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2008;51:828–35.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 828-835
    • Fauchier, L.1    Pierre, B.2    de Labriolle, A.3    Grimard, C.4    Zannad, N.5    Babuty, D.6
  • 29
    • 84879105232 scopus 로고    scopus 로고
    • Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation
    • COI: 1:CAS:528:DC%2BC3sXptlKrtb4%3D, PID: 23640485
    • Tanaka S, Fukumoto Y, Nochioka K, Minami T, Kudo S, Shiba N, Takai Y, Williams CL, Liao JK, Shimokawa H. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol. 2013;33:1591–600.
    • (2013) Arterioscler Thromb Vasc Biol , vol.33 , pp. 1591-1600
    • Tanaka, S.1    Fukumoto, Y.2    Nochioka, K.3    Minami, T.4    Kudo, S.5    Shiba, N.6    Takai, Y.7    Williams, C.L.8    Liao, J.K.9    Shimokawa, H.10
  • 30
    • 0032584177 scopus 로고    scopus 로고
    • Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
    • COI: 1:CAS:528:DyaK1cXisVWmsrY%3D, PID: 9537338
    • Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97:1129–35.
    • (1998) Circulation , vol.97 , pp. 1129-1135
    • Laufs, U.1    La Fata, V.2    Plutzky, J.3    Liao, J.K.4
  • 31
    • 0037419766 scopus 로고    scopus 로고
    • Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway
    • COI: 1:CAS:528:DC%2BD3sXhvFCitbg%3D, PID: 12575984
    • Bell RM, Yellon DM. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol. 2003;41:508–15.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 508-515
    • Bell, R.M.1    Yellon, D.M.2
  • 33
    • 0034758721 scopus 로고    scopus 로고
    • Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion
    • COI: 1:CAS:528:DC%2BD3MXnslCrt74%3D, PID: 11676559
    • Joyce M, Kelly C, Winter D, Chen G, Leahy A, Bouchier-Hayes D. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion. J Surg Res. 2001;101:79–84.
    • (2001) J Surg Res , vol.101 , pp. 79-84
    • Joyce, M.1    Kelly, C.2    Winter, D.3    Chen, G.4    Leahy, A.5    Bouchier-Hayes, D.6
  • 36
    • 33646519915 scopus 로고    scopus 로고
    • Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects
    • COI: 1:CAS:528:DC%2BD28XjvF2ksrg%3D, PID: 16557230
    • Yasuda H, Yuen PST, Hu X, Zhou H, Star RA. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int. 2006;69:1535–42.
    • (2006) Kidney Int , vol.69 , pp. 1535-1542
    • Yasuda, H.1    Yuen, P.S.T.2    Hu, X.3    Zhou, H.4    Star, R.A.5
  • 38
    • 84959267840 scopus 로고    scopus 로고
    • High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial
    • COI: 1:CAS:528:DC%2BC28XhtlGrt77F, PID: 26906014
    • Billings FT 4th, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877–88.
    • (2016) JAMA , vol.315 , pp. 877-888
    • Billings, F.T.1    Hendricks, P.A.2    Schildcrout, J.S.3    Shi, Y.4    Petracek, M.R.5    Byrne, J.G.6    Brown, N.J.7
  • 40
    • 84902136264 scopus 로고    scopus 로고
    • Therapeutic translation in acute kidney injury: the epithelial/endothelial axis
    • COI: 1:CAS:528:DC%2BC2cXpvFaiur4%3D, PID: 24892710
    • Molitoris BA. Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. J Clin Invest. 2014;124:2355–63.
    • (2014) J Clin Invest , vol.124 , pp. 2355-2363
    • Molitoris, B.A.1
  • 41
    • 17344385356 scopus 로고    scopus 로고
    • The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC
    • COI: 1:CAS:528:DC%2BD38XnsVCkur0%3D, PID: 12226549
    • Morikawa S, Takabe W, Mataki C, Kanke T, Itoh T, Wada Y, Izumi A, Saito Y, Hamakubo T, Kodama T. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. J Atheroscler Thromb. 2002;9:178–83.
    • (2002) J Atheroscler Thromb , vol.9 , pp. 178-183
    • Morikawa, S.1    Takabe, W.2    Mataki, C.3    Kanke, T.4    Itoh, T.5    Wada, Y.6    Izumi, A.7    Saito, Y.8    Hamakubo, T.9    Kodama, T.10
  • 42
    • 84878842316 scopus 로고    scopus 로고
    • Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation
    • COI: 1:CAS:528:DC%2BC3sXnsVGltLg%3D, PID: 23608189
    • Wu K, Tian S, Zhou H, Wu Y. Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation. Biochem Pharmacol. 2013;85:1753–60.
    • (2013) Biochem Pharmacol , vol.85 , pp. 1753-1760
    • Wu, K.1    Tian, S.2    Zhou, H.3    Wu, Y.4
  • 43
    • 78149481592 scopus 로고    scopus 로고
    • Mammalian Krüppel-like factors in health and diseases
    • COI: 1:CAS:528:DC%2BC3cXhsFSqtbjM, PID: 20959618
    • McConnell BB, Yang VW. Mammalian Krüppel-like factors in health and diseases. Physiol Rev. 2010;90:1337–81.
    • (2010) Physiol Rev , vol.90 , pp. 1337-1381
    • McConnell, B.B.1    Yang, V.W.2
  • 44
    • 84901505578 scopus 로고    scopus 로고
    • Role of Krüppel-like factor 4 and its binding proteins in vascular disease
    • PID: 24573018
    • Yoshida T, Hayashi M. Role of Krüppel-like factor 4 and its binding proteins in vascular disease. J Atheroscler Thromb. 2014;21:402–13.
    • (2014) J Atheroscler Thromb , vol.21 , pp. 402-413
    • Yoshida, T.1    Hayashi, M.2
  • 45
    • 77954231839 scopus 로고    scopus 로고
    • Smooth and cardiac muscle-selective knock-out of Krüppel-like factor 4 causes postnatal death and growth retardation
    • COI: 1:CAS:528:DC%2BC3cXnvFShsr0%3D, PID: 20439457
    • Yoshida T, Gan Q, Franke AS, Ho R, Zhang J, Chen YE, Hayashi M, Majesky MW, Somlyo AV, Owens GK. Smooth and cardiac muscle-selective knock-out of Krüppel-like factor 4 causes postnatal death and growth retardation. J Biol Chem. 2010;285:21175–84.
    • (2010) J Biol Chem , vol.285 , pp. 21175-21184
    • Yoshida, T.1    Gan, Q.2    Franke, A.S.3    Ho, R.4    Zhang, J.5    Chen, Y.E.6    Hayashi, M.7    Majesky, M.W.8    Somlyo, A.V.9    Owens, G.K.10
  • 46
    • 0036340041 scopus 로고    scopus 로고
    • The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon
    • COI: 1:CAS:528:DC%2BD38XltVyhsb8%3D, PID: 12015290
    • Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW, Kaestner KH. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development. 2002;129:2619–28.
    • (2002) Development , vol.129 , pp. 2619-2628
    • Katz, J.P.1    Perreault, N.2    Goldstein, B.G.3    Lee, C.S.4    Labosky, P.A.5    Yang, V.W.6    Kaestner, K.H.7
  • 47
    • 17144401799 scopus 로고    scopus 로고
    • Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach
    • COI: 1:CAS:528:DC%2BD2MXjvV2qt7o%3D, PID: 15825076
    • Katz JP, Perreault N, Goldstein BG, Actman L, McNally SR, Silberg DG, Furth EE, Kaestner KH. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology. 2005;128:935–45.
    • (2005) Gastroenterology , vol.128 , pp. 935-945
    • Katz, J.P.1    Perreault, N.2    Goldstein, B.G.3    Actman, L.4    McNally, S.R.5    Silberg, D.G.6    Furth, E.E.7    Kaestner, K.H.8
  • 48
    • 84962826169 scopus 로고    scopus 로고
    • KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprogramming during early pancreatic carcinogenesis
    • COI: 1:CAS:528:DC%2BC28XksVWitLk%3D, PID: 26977883
    • Wei D, Wang L, Yan Y, Jia Z, Gagea M, Li Z, Zuo X, Kong X, Huang S, Xie K. KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprogramming during early pancreatic carcinogenesis. Cancer Cell. 2016;29:324–38.
    • (2016) Cancer Cell , vol.29 , pp. 324-338
    • Wei, D.1    Wang, L.2    Yan, Y.3    Jia, Z.4    Gagea, M.5    Li, Z.6    Zuo, X.7    Kong, X.8    Huang, S.9    Xie, K.10
  • 50
    • 84907203964 scopus 로고    scopus 로고
    • Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity
    • COI: 1:CAS:528:DC%2BC2cXhsFOqtrjI, PID: 25100730
    • Yoshida T, Yamashita M, Horimai C, Hayashi M. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. J Biol Chem. 2014;289:26107–18.
    • (2014) J Biol Chem , vol.289 , pp. 26107-26118
    • Yoshida, T.1    Yamashita, M.2    Horimai, C.3    Hayashi, M.4
  • 51
    • 33747195353 scopus 로고    scopus 로고
    • Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by deflined factors
    • COI: 1:CAS:528:DC%2BD28Xpt1aktbs%3D, PID: 16904174
    • Takahashi K, Yamanka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by deflined factors. Cell. 2006;126:663–76.
    • (2006) Cell , vol.126 , pp. 663-676
    • Takahashi, K.1    Yamanka, S.2
  • 53
    • 48249113711 scopus 로고    scopus 로고
    • Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury
    • COI: 1:CAS:528:DC%2BD1cXmvFOhsbg%3D, PID: 18483411
    • Yoshida T, Kaestner KH, Owens GK. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res. 2008;102:1548–57.
    • (2008) Circ Res , vol.102 , pp. 1548-1557
    • Yoshida, T.1    Kaestner, K.H.2    Owens, G.K.3
  • 55
    • 84898611844 scopus 로고    scopus 로고
    • Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury
    • PID: 24470523
    • Yoshida T, Yamashita M, Horimai C, Hayashi M. Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury. J Am Heart Assoc. 2014;3:e000622.
    • (2014) J Am Heart Assoc , vol.3
    • Yoshida, T.1    Yamashita, M.2    Horimai, C.3    Hayashi, M.4
  • 56
    • 84983786606 scopus 로고    scopus 로고
    • Endothelial Krüppel-like factor 4 mediates the protective effect of statins against ischemic AKI
    • COI: 1:CAS:528:DC%2BC28XitFSjtL7L, PID: 26471129
    • Yoshida T, Yamashita M, Iwai M, Hayashi M. Endothelial Krüppel-like factor 4 mediates the protective effect of statins against ischemic AKI. J Am Soc Nephrol. 2016;27:1379–88.
    • (2016) J Am Soc Nephrol , vol.27 , pp. 1379-1388
    • Yoshida, T.1    Yamashita, M.2    Iwai, M.3    Hayashi, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.